The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors

Goodarz Danaei, Eric L Ding, Dariush Mozaffarian, Ben Taylor, Jürgen Rehm, Christopher J L Murray, Majid Ezzati, Goodarz Danaei, Eric L Ding, Dariush Mozaffarian, Ben Taylor, Jürgen Rehm, Christopher J L Murray, Majid Ezzati

Abstract

Background: Knowledge of the number of deaths caused by risk factors is needed for health policy and priority setting. Our aim was to estimate the mortality effects of the following 12 modifiable dietary, lifestyle, and metabolic risk factors in the United States (US) using consistent and comparable methods: high blood glucose, low-density lipoprotein (LDL) cholesterol, and blood pressure; overweight-obesity; high dietary trans fatty acids and salt; low dietary polyunsaturated fatty acids, omega-3 fatty acids (seafood), and fruits and vegetables; physical inactivity; alcohol use; and tobacco smoking.

Methods and findings: We used data on risk factor exposures in the US population from nationally representative health surveys and disease-specific mortality statistics from the National Center for Health Statistics. We obtained the etiological effects of risk factors on disease-specific mortality, by age, from systematic reviews and meta-analyses of epidemiological studies that had adjusted (i) for major potential confounders, and (ii) where possible for regression dilution bias. We estimated the number of disease-specific deaths attributable to all non-optimal levels of each risk factor exposure, by age and sex. In 2005, tobacco smoking and high blood pressure were responsible for an estimated 467,000 (95% confidence interval [CI] 436,000-500,000) and 395,000 (372,000-414,000) deaths, accounting for about one in five or six deaths in US adults. Overweight-obesity (216,000; 188,000-237,000) and physical inactivity (191,000; 164,000-222,000) were each responsible for nearly 1 in 10 deaths. High dietary salt (102,000; 97,000-107,000), low dietary omega-3 fatty acids (84,000; 72,000-96,000), and high dietary trans fatty acids (82,000; 63,000-97,000) were the dietary risks with the largest mortality effects. Although 26,000 (23,000-40,000) deaths from ischemic heart disease, ischemic stroke, and diabetes were averted by current alcohol use, they were outweighed by 90,000 (88,000-94,000) deaths from other cardiovascular diseases, cancers, liver cirrhosis, pancreatitis, alcohol use disorders, road traffic and other injuries, and violence.

Conclusions: Smoking and high blood pressure, which both have effective interventions, are responsible for the largest number of deaths in the US. Other dietary, lifestyle, and metabolic risk factors for chronic diseases also cause a substantial number of deaths in the US.

Conflict of interest statement

The Academic Editor declares that he had no competing interests when the first version of this paper was submitted. After a revised version was submitted, he started working on the global burden of disease from climate change project at the WHO in Geneva. Majid Ezzati is also working on the Global Burden of Disease project.

Figures

Figure 1. Deaths attributable to total effects…
Figure 1. Deaths attributable to total effects of individual risk factors, by disease.
Data are shown for both sexes combined (upper graph); men (middle graph); and women (lower graph). See Table 8 for 95% CIs. Notes: We used RRs for blood pressure, LDL cholesterol, and FPG that were adjusted for regression dilution bias using studies that had repeated exposure measurement ,,; for blood pressure and LDL cholesterol, the adjusted magnitude is supported by effect sizes from randomized studies ,. Evidence from a large prospective study using multiple measurements of weight and height showed that regression dilution bias did not affect the RRs for BMI, possibly because there is less variability . RRs for dietary salt and PUFA were from intervention studies, and hence unlikely to be affected by regression dilution bias. RRs for dietary trans fatty acids were primarily from studies that had used cumulative averaging of repeated measurements that reduces but may not fully correct for regression dilution bias. RRs for physical inactivity, alcohol use, smoking, and dietary omega-3 fatty acids and fruits and vegetables were not corrected for regression dilution bias due to insufficient current information from epidemiological studies on exposure measurement error and variability, which is especially important when error and variability of self-reported exposure may themselves differ across studies. Regression dilution bias often, although not always, underestimates RRs in multivariate analysis . aThe figures show deaths attributable to the total effects of each individual risk. There is overlap between the effects of risk factors because of multicausality and because the effects of some risk factors are partly mediated through other risks. Therefore, the number of deaths attributable to individual risks cannot be added. bThe effect of high dietary salt on cardiovascular diseases was estimated through its measured effects on systolic blood pressure. cThe protective effects of alcohol use on cardiovascular diseases are its net effects. Regular moderate alcohol use is protective for IHD, ischemic stroke, and diabetes, but any use is hazardous for hypertensive disease, hemorrhagic stroke, cardiac arrhythmias, and other cardiovascular diseases. NCD, noncommunicable diseases.
Figure 2. Deaths attributable to total effects…
Figure 2. Deaths attributable to total effects of individual risk factors, by disease in those below 70 years of age.
Data are shown for both sexes combined (upper graph); men (middle graph); and women (lower graph). See Figure 1 notes.

References

    1. McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA. 1993;270:2207–2212.
    1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747–1757.
    1. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291:1238–1245.
    1. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 1986;124:17–27.
    1. Stahre M, Naimi T, Brewer R, Holt J. Measuring average alcohol consumption: the impact of including binge drinks in quantity-frequency calculations. Addiction. 2006;101:1711–1718.
    1. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765–774.
    1. Lawes CM, Parag V, Bennett DA, Suh I, Lam TH, et al. Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care. 2004;27:2836–2842.
    1. Law MR, Wald NJ, Wu T, Hackshaw A, Bailey A. Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study. BMJ. 1994;308:363–366.
    1. Emberson JR, Whincup PH, Morris RW, Wannamethee SG, Shaper AG. Lifestyle and cardiovascular disease in middle-aged British men: the effect of adjusting for within-person variation. Eur Heart J. 2005;26:1774–1782.
    1. Emberson JR, Shaper AG, Wannamethee SG, Morris RW, Whincup PH. Alcohol intake in middle age and risk of cardiovascular disease and mortality: accounting for intake variation over time. Am J Epidemiol. 2005;161:856–863.
    1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913.
    1. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ. 2003;326:1423.
    1. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994;308:367–372.
    1. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827–838.
    1. Reeves GK, Pirie K, Beral V, Green J, Spencer E, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007;335:1134.
    1. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006;354:1601–1613.
    1. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569–578.
    1. Peto R, Lopez AD, Boreham J, Thun M, Heath C., Jr Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet. 1992;339:1268–1278.
    1. Rehm J, Room R, Monteiro M, Gmel G, Graham K, et al. Alcohol use. In: Ezzati M, Lopez AD, Rogers A, Murray CJL, editors. Comparative quantification of health risks: Global and regional burden of disease attributable to selected major risk factors. Geneva: WHO; 2004. pp. 959–1108.
    1. Zhang X, Patel A, Horibe H, Wu Z, Barzi F, et al. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol. 2003;32:563–572.
    1. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–952.
    1. Murray CJ, Kulkarni SC, Ezzati M. Understanding the coronary heart disease versus total cardiovascular mortality paradox: a method to enhance the comparability of cardiovascular death statistics in the United States. Circulation. 2006;113:2071–2081.
    1. Murray CJ, Dias RH, Kulkarni SC, Lozano R, Stevens GA, et al. Improving the comparability of diabetes mortality statistics in the U.S. and Mexico. Diabetes Care. 2008;31:451–458.
    1. Lu TH, Hsu PY, Bjorkenstam C, Anderson RN. Certifying diabetes-related cause-of-death: a comparison of inappropriate certification statements in Sweden, Taiwan and the USA. Diabetologia. 2006;49:2878–2881.
    1. Rosamond W, Flegal K, Friday G, Furie K, Go A, et al. Heart disease and stroke statistics–2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69–171.
    1. Sudlow CL, Warlow CP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke. 1997;28:491–499.
    1. Borges G, Cherpitel C, Orozco R, Bond J, Ye Y, et al. Multicentre study of acute alcohol use and non-fatal injuries: data from the WHO collaborative study on alcohol and injuries. Bull World Health Organ. 2006;84:453–460.
    1. Cherpitel CJ, Bond J, Ye Y. Alcohol and injury: a risk function analysis from the Emergency Room Collaborative Alcohol Analysis Project (ERCAAP). Eur Addict Res. 2006;12:42–52.
    1. Puddey IB, Rakic V, Dimmitt SB, Beilin LJ. Influence of pattern of drinking on cardiovascular disease and cardiovascular risk factors–a review. Addiction. 1999;94:649–663.
    1. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction. 2000;95:1505–1523.
    1. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296:1885–1899.
    1. Greenland S. Bias in methods for deriving standardized morbidity ratio and attributable fraction estimates. Stat Med. 1984;3:131–141.
    1. Spiegelman D, Hertzmark E, Wand HC. Point and interval estimates of partial population attributable risks in cohort studies: examples and software. Cancer Causes Control. 2007;18:571–579.
    1. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol. 1985;122:904–914.
    1. Greenland S, Drescher K. Maximum likelihood estimation of the attributable fraction from logistic models. Biometrics. 1993;49:865–872.
    1. Flegal KM, Graubard BI, Williamson DF. Methods of calculating deaths attributable to obesity. Am J Epidemiol. 2004;160:331–338.
    1. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III—Analysis of data from trials of salt reduction. BMJ. 1991;302:819–824.
    1. He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens. 2002;16:761–770.
    1. Ezzati M, Oza S, Danaei G, Murray CJ. Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States. Circulation. 2008;117:905–914.
    1. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004;328:1519.
    1. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345:790–797.
    1. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
    1. Balkau B, Shipley M, Jarrett RJ, Pyorala K, Pyorala M, et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care. 1998;21:360–367.
    1. Gerstein HC, Miller ME, Byington RP, Goff DC, Jr, Bigger JT, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–2559.
    1. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–2572.
    1. Ezzati M, Vander Hoorn S, Rodgers A, Lopez AD, Mathers CD, et al. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet. 2003;362:271–280.
    1. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.
    1. Clarke R, Shipley M, Lewington S, Youngman L, Collins R, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150:341–353.
    1. International Agency for Research on Cancer. Tobacco Control: Reversal of Risk after Quitting Smoking: IARC Handbooks of Cancer Prevention, Volume 11. Geneva: World Health Organization Press; 2007.
    1. Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA. 2005;20;293:1868–1874.
    1. Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007;298:2028–2037.
    1. Ni MC, Rodgers A, Pan WH, Gu DF, Woodward M. Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol. 2004;33:751–758.
    1. Institute of Medicine. Care Without Coverage: Too Little, Too Late. Washington D.C.: National Academy Press; 2002.
    1. Ezzati M, Vander HS, Lawes CM, Leach R, James WP, et al. Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med. 2005;2:e133.
    1. Stevens G, Dias RH, Thomas KJ, Rivera JA, Carvalho N, et al. Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors. PLoS Med. 2008;5:e125.
    1. Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet. 2003;361:717–725.
    1. Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet. 2007;370:2044–2053.
    1. Lim SS, Gaziano TA, Gakidou E, Reddy KS, Farzadfar F, et al. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet. 2007;370:2054–2062.
    1. [Anonymous] Tobacco use–United States, 1900–1999. MMWR Morb Mortal Wkly Rep. 1999;48:986–993.
    1. Ezzati M, Martin H, Skjold S, Vander HS, Murray CJ. Trends in national and state-level obesity in the USA after correction for self-report bias: analysis of health surveys. J R Soc Med. 2006;99:250–257.
    1. Danaei G, Lawes CM, Vander HS, Murray CJ, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet. 2006;368:1651–1659.
    1. Barter P, Rye KA. Are we lowering LDL cholesterol sufficiently? Nat Clin Pract Cardiovasc Med. 2006;3:290–291.
    1. Lawes C, Vander Hoorn S, Law M, Elliott P, MacMahon S, et al. High blood pressure. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks: Global and regional burden of disease attributable to selected major risk factors. Geneva: WHO; 2004. pp. 281–389.
    1. [Anonymous] Blood pressure, cholesterol, and stroke in eastern Asia. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Lancet. 1998;352:1801–1807.
    1. James WPT, Jackson-Leach R, Mhurchu CN, Kalamara E, Shayeghi M, et al. Overweight and obesity (High body mass index). In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks: Global and regional burden of disease attributable to selected major risk factors. Geneva: WHO; 2004. pp. 497–596.
    1. Havas S, Roccella EJ, Lenfant C. Reducing the public health burden from elevated blood pressure levels in the United States by lowering intake of dietary sodium. Am J Public Health. 2004;94:19–22.
    1. Lock K, Pomerleau J, Causer L, McKee M. Low fruit and vegetable consumption. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks: Global and regional burden of disease attributable to selected major risk factors. Geneva: WHO; 2004. pp. 597–728.
    1. Allison DB, Egan SK, Barraj LM, Caughman C, Infante M, et al. Estimated intakes of trans fatty and other fatty acids in the US population. J Am Diet Assoc. 1999;99:166–174.
    1. Manson JE, Hu FB, Rich-Edwards JW, Colditz GA, Stampfer MJ, et al. A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med. 1999;341:650–658.
    1. Hu FB, Stampfer MJ, Colditz GA, Ascherio A, Rexrode KM, et al. Physical activity and risk of stroke in women. JAMA. 2000;283:2961–2967.
    1. Patel AV, Callel EE, Bernstein L, Wu AH, Thun MJ. Recreational physical activity and risk of postmenopausal breast cancer in a large cohort of US women. Cancer Causes Control. 2003;14:519–529.
    1. Chao A, Connell CJ, Jacobs EJ, McCullough ML, Patel AV, et al. Amount, type, and timing of recreational physical activity in relation to colon and rectal cancer in older adults: the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev. 2004;13:2187–2195.
    1. US Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2004.
    1. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington D.C.: American Institute for Cancer Research; 2007.
    1. Dauchet L, Amouyel P, Hercberg S, Dallongeville J. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr. 2006;136:2588–2593.
    1. Dauchet L, Amouyel P, Dallongeville J. Fruit and vegetable consumption and risk of stroke: a meta-analysis of cohort studies. Neurology. 2005;65:1193–1197.
    1. Boeing H, Dietrich T, Hoffmann K, Pischon T, Ferrari P, et al. Intake of fruits and vegetables and risk of cancer of the upper aero-digestive tract: the prospective EPIC-study. Cancer Causes Control. 2006;17:957–969.
    1. Jakobsen MU, O'Reilly EJ, Heitmann BL, Pereira MA, Balter K, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009 E-pub ahead of print. doi: .
    1. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135:1301–1309.
    1. Bagnardi V, Scotti L, La Vecchia C, Zatonski W. Binge drinking and cardiovascular disease: a meta-analysis. J Epidemiol Community Med. 2008;62:615–619.
    1. Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, et al. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289:579–588.
    1. Gutjahr E, Gmel G, Rehm J. Relation between average alcohol consumption and disease: an overview. Eur Addict Res. 2001;7:117–127.
    1. Ridolfo S, Stevenson C. The quantification of drug-caused mortality and morbidity in Australia 1998. Canberra: Australian Institute of Health and Welfare; 2001.
    1. Cho E, Smith-Warner SA, Ritz J, van den Brandt PA, Colditz GA, et al. Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med. 2004;140:603–613.
    1. Corrao G, Bagnardi V, Zambon A, Arico S. Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: a meta-analysis. Addiction. 1999;94:1551–1573.
    1. Hurst PM, Harte D, Frith WJ. The Grand Rapids dip revisited. Accid Anal Prev. 1994;26:647–654.
    1. Bull F, Armstrong T, Dixon T, Ham S, Neiman A, et al. Physical inactivity. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks: Global and regional burden of disease attributable to selected major risk factors. Geneva: WHO; 2004. pp. 729–882.
    1. Ezzati M, Henley SJ, Thun MJ, Lopez AD. Role of smoking in global and regional cardiovascular mortality. Circulation. 2005;112:489–497.
    1. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007;298:2654–2664.
    1. Ezzati M, Henley SJ, Lopez AD, Thun MJ. Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer. 2005;116:963–971.
    1. Chao A, Thun MJ, Jacobs EJ, Henley SJ, Rodriguez C, et al. Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst. 2000;92:1888–1896.
    1. Thun MJ, Apicella LF, Henley SJ. Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom. JAMA. 2000;284:706–712.
    1. Lin HH, Ezzati M, Murray M. Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med. 2007;4:e20.
    1. [No authors listed] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–853.
    1. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370:1829–1839.
    1. Ni MC, Parag V, Nakamura M, Patel A, Rodgers A, et al. Body mass index and risk of diabetes mellitus in the Asia-Pacific region. Asia Pac J Clin Nutr. 2006;15:127–133.
    1. Lawes CC, Vander Hoorn S, Law MR, Rodgers A. High cholesterol. In: Ezzati M, Lopez AD, Murray CJ, Rodgers A, editors. Comparative quantification of health risks: Global and regional burden of disease attributable to selected major risk factors. Geneva: WHO; 2004. pp. 1651–1801.
    1. Collins R, Armitage J, Parish S, Sleight P, Peto R. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004;363:757–767.
    1. Libby P, Aikawa M. Mechanisms of plaque stabilization with statins. Am J Cardiol. 2003;91:4B–8B.
    1. Willett W, Stampfer MJ, Bain C, Lipnick R, Speizer FE, et al. Cigarette smoking, relative weight, and menopause. Am J Epidemiol. 1983;117:651–658.
    1. Manson JE, Bassuk SS, Hu FB, Stampfer MJ, Colditz GA, et al. Estimating the number of deaths due to obesity: can the divergent findings be reconciled? J Womens Health (Larchmt) 2007;16:168–176.
    1. Whitlock G, Lewington S, Mhurchu CN. Coronary heart disease and body mass index: a systematic review of the evidence from larger prospective cohort studies. Semin Vasc Med. 2002;2:369–381.
    1. [No authors listed] Screening for type 2 diabetes mellitus in adults: recommendations and rationale. Am J Nurs. 2004;104:83–90, 92.
    1. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Jr, Clark LT, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227–239.
    1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572.
    1. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47:296–308.
    1. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995;273:402–407.

Source: PubMed

3
Tilaa